The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)

D Coghill, T Banaschewski, S Cortese… - European child & …, 2021 - Springer
ADHD is the most common neurodevelopmental disorder presenting to child and adolescent
mental health, paediatric, and primary care services. Timely and effective interventions to …

[HTML][HTML] Half a century of research on attention-deficit/hyperactivity disorder: a scientometric study

S Cortese, M Sabé, C Chen, N Perroud… - … & Biobehavioral Reviews, 2022 - Elsevier
We performed a scientometric analysis of the scientific literature on ADHD to evaluate key
themes and trends over the past decades, informing future lines of research. We conducted …

ADHD: Reviewing the causes and evaluating solutions

L Núñez-Jaramillo, A Herrera-Solís… - Journal of personalized …, 2021 - mdpi.com
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder in which
patients present inattention, hyperactivity, and impulsivity. The etiology of this condition is …

Adult outcome as seen through controlled prospective follow-up studies of children with attention-deficit/hyperactivity disorder followed into adulthood

MV Cherkasova, A Roy, BSG Molina, G Scott… - Journal of the American …, 2022 - Elsevier
Objective To describe adult outcome of people with attention-deficit/hyperactivity disorder
(ADHD) diagnosed in childhood and its several key predictors via a review of 7 North …

Treatment biomarkers for ADHD: Taking stock and moving forward

G Michelini, LJ Norman, P Shaw, SK Loo - Translational psychiatry, 2022 - nature.com
The development of treatment biomarkers for psychiatric disorders has been challenging,
particularly for heterogeneous neurodevelopmental conditions such as attention …

Patterns of long-term ADHD medication use in Australian children

D Efron, M Mulraney, E Sciberras, H Hiscock… - Archives of disease in …, 2020 - adc.bmj.com
Objective Adherence to attention-deficit/hyperactivity disorder (ADHD) medication treatment
is often suboptimal. This can compromise patient outcomes. We aimed to describe the …

Effects of discontinuing methylphenidate on strengths and difficulties, quality of life and parenting stress

AFM Matthijssen, A Dietrich, M Bierens… - Journal of Child and …, 2020 - liebertpub.com
Objectives: To study the effects of discontinuation of long-term methylphenidate use on
secondary outcome measures of strengths and difficulties, quality of life (QoL), and …

Causal modelling of variation in clinical practice and long-term outcomes of ADHD using Norwegian registry data: the ADHD controversy project

A Mykletun, T Widding-Havneraas, A Chaulagain… - BMJ open, 2021 - bmjopen.bmj.com
Introduction Attention-deficit/hyperactivity disorder (ADHD) is among the most common
mental disorders in children and adolescents, and it is a strong risk factor for several …

The Services Provided to Students with Attention Deficit Hyperactivity Disorder in Primary Schools from the Special Education Teachers' Perspectives

M Alnaim - International Journal of Learning, Teaching and …, 2023 - ijlter.net
The study aimed to investigate the reality and challenges of the special education services
provided to students with attention deficit hyperactivity disorder (ADHD) in primary schools in …

La prescription de méthylphénidate chez l'enfant et l'adolescent en France: caractéristiques et évolution entre 2010 et 2019

S Ponnou, H Haliday, B Thomé, F Gonon - … de l'Enfance et de l' …, 2022 - Elsevier
Résumé Contexte La prescription de médicaments psychotropes aux enfants et adolescents
pour alléger les symptômes du Trouble déficitaire de l'attention avec ou sans hyperactivité …